Q4FY17 Results : Sanofi India
Amir Shaikh / 05 May 2017
Total sales for this quarter, Q4FY17, came in at Rs. 512.7 crore. This represents a 9.2 per cent sequential decline and 1.1 per cent YoY decline.
Sanofi India Ltd. reported its results for the quarter ended March 31, 2017 on Friday. The consolidated numbers were largely negative.
Total sales for this quarter, Q4FY17, came in at Rs. 512.7 crore. This represents a 9.2 per cent sequential decline and 1.1 per cent YoY decline.
Operating profit (EBIT) for the recently concluded quarter amounted to Rs. 36 crore and the EBIT margin stood at 7.02 per cent.
The company reported PAT worth Rs. 60 crore which represents a sequential QoQ increase of 12.8 per cent and a YoY decline of 27.4 per cent.
The stock opened at Rs. 4233 and touched an intra-day low of Rs. 4140 and finally closed at Rs. 4175 on BSE on Friday.
Sanofi India Ltd. is a pharmaceutical company. The company’s product portfolio includes medicines for several therapeutic areas including cardiovascular, thrombotic, metabolic disorders, oncology, disorders of the central nervous system, internal medicine.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.